Page last updated: 2024-08-25

ubenimex and Pituitary Neoplasms

ubenimex has been researched along with Pituitary Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fu, Y; Pang, B; Pang, Q; Wang, Y; Zhang, R	1

Other Studies

1 other study(ies) available for ubenimex and Pituitary Neoplasms

Article	Year
Ubenimex induces apoptotic and autophagic cell death in rat GH3 and MMQ cells through the ROS/ERK pathway. Drug design, development and therapy, 2019, Volume: 13 Topics: Adenoma; Animals; Antibiotics, Antineoplastic; Apoptosis; Autophagic Cell Death; Autophagosomes; Cell Line, Tumor; Cell Survival; Extracellular Signal-Regulated MAP Kinases; Leucine; MAP Kinase Signaling System; Pituitary Neoplasms; Rats; Reactive Oxygen Species	2019

Article

Year

Ubenimex induces apoptotic and autophagic cell death in rat GH3 and MMQ cells through the ROS/ERK pathway.

Drug design, development and therapy, 2019, Volume: 13

Topics: Adenoma; Animals; Antibiotics, Antineoplastic; Apoptosis; Autophagic Cell Death; Autophagosomes; Cell Line, Tumor; Cell Survival; Extracellular Signal-Regulated MAP Kinases; Leucine; MAP Kinase Signaling System; Pituitary Neoplasms; Rats; Reactive Oxygen Species

2019